Efficacious Cefazolin Prophylactic Dose for Morbidly Obese Women Undergoing Bariatric Surgery Based on Evidence from Subcutaneous Microdialysis and Populational Pharmacokinetic Modeling

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmaceutical Research

• Publication date

  2018-04-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11095-018-2394-5PMID 29644481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fast and sensitive HPLC/UV method for cefazolin quantification in plasma and subcutaneous tissue microdialysate of humans and rodents applied to pharmacokinetic studies in obese individuals.

  2018cited by this paper
• Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients

  2017cited by this paper
• Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing

  2017cited by this paper
• Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery

  2017cited by this paper
• Influence of Experimental Cryptococcal Meningitis in Wistar Rats on Voriconazole Brain Penetration Assessed by Microdialysis

  2017cited by this paper
• New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective.

  2016cited by this paper
• Obesity and the Risk for Surgical Site Infection in Abdominal Surgery

  2016cited by this paper
• Trends in Obesity Among Adults in the United States, 2005 to 2014.

  2016cited by this paper
• Surgical site infections 2 New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective

  2016cited by this paper
• Bariatric surgery implementation trends in the USA from 2002 to 2012

  2015cited by this paper
• Direct Healthcare Cost of Obesity in Brazil: An Application of the Cost-of-Illness Method from the Perspective of the Public Health System in 2011

  2015cited by this paper
• Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

  2015cited by this paper
• Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.

  2015cited by this paper
• Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.

  2014cited by this paper
• Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates.

  2014cited by this paper
• Antibiotic Prophylaxis in Bariatric Surgery with Continuous Infusion of Cefazolin: Determination of Concentration in Adipose Tissue

  2014cited by this paper
• Antibiotic prophylaxis in obese patients submitted to bariatric surgery. A systematic review.

  2014cited by this paper
• Cefazolin plasma protein binding in different human populations: more than cefazolin-albumin interaction.

  2014cited by this paper
• Surgery for weight loss in adults.

  2014cited by this paper
• Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals.

  2014cited by this paper
• Pharmacodynamic modelling of intravenous antibiotic prophylaxis in elective colorectal surgery.

  2013cited by this paper
• Clinical practice guidelines for antimicrobial prophylaxis in surgery.

  2013cited by this paper
• Cefazolin Dosing for Surgical Prophylaxis in Morbidly Obese Patients

  2012cited by this paper
• On the accuracy of determination of unbound drug fraction in tissue using diluted tissue homogenate.

  2012cited by this paper
• On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.

  2011cited by this paper
• Pharmacokinetics and protein binding of cefazolin in morbidly obese patients

  2011cited by this paper
• Structured telephone support or telemonitoring programmes for patients with chronic heart failure

  2010cited by this paper
• Trends in Morbid Obesity and in Bariatric Surgeries Covered by the Brazilian Public Health System

  2010cited by this paper
• Protein binding of cefazolin is saturable in vivo both between and within patients.

  2007cited by this paper
• Comparison of Bariatric and Non-Bariatric Elective Operations in Morbidly Obese Patients on the Basis of Wound Infection

  2005cited by this paper
• Meta-Analysis: Surgical Treatment of Obesity

  2005cited by this paper
• Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels?

  2004cited by this paper
• Age-related change of cefazolin binding to rat serum proteins and its relation to the molar ratio of free fatty acid to serum albumin.

  1986cited by this paper
• Physiologically Based Pharmacokinetic Model for β-Lactam Antibiotics I: Tissue Distribution and Elimanation Rates

  1983cited by this paper
• Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.

  1983cited by this paper

• β-Lactam Antibiotics in Obese Adults: A Review of Population Pharmacokinetic Analyses.

  2026cites this paper
• Peri-Operative Dosage and Therapeutic Concentrations of Cefazolin Administered for Surgical Site Infection Prophylaxis in Elective Surgery—A Systematic Review

  2025influential citation
• The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments.

  2025cites this paper
• Surgical Antibiotic Prophylaxis Dosing in Adult Patients with Obesity: A Comprehensive Review of Pharmacokinetic and Pharmacodynamic Data

  2025influential citation
• Les principes de l’antibioprophylaxie au bloc opératoire

  2024cites this paper
• Population Pharmacokinetics and Pharmacodynamics of Cefazolin Using Total and Unbound Serum Concentrations in Patients with High Body Weight.

  2023cites this paper
• Paddle Lead Spinal Cord Stimulation in the Morbidly Obese Patient Population: Outcomes and Complications in a Single-Surgeon Cohort.

  2023cites this paper
• Effective Antimicrobial Prophylaxis in Surgery: The Relevance and Role of Pharmacokinetics-Pharmacodynamics

  2023cites this paper
• Individualized surgical antibiotic prophylaxis – why, when, and how?

  2022cites this paper
• Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients

  2022cites this paper
• A validated LC-MS/MS method for the quantitation of cefazolin in human adipose tissue: Application of EMR-Lipid sorbent as an efficient sample clean-up before mass spectrometric analyses.

  2022cites this paper
• Prophylactic Cefazolin Dosing in Obesity—a Systematic Review

  2022cites this paper
• Perioperative administration of cefazolin and metronidazole in obese and non-obese patients: a pharmacokinetic study in plasma and interstitial fluid.

  2021cites this paper
• [Anti-infective treatment in obesity-"just double it?"]

  2020cites this paper
• Antiinfektive Therapie bei Adipositas – „einfach das Doppelte?“

  2020cites this paper
• Reassessing the dosing of cefoxitin prophylaxis during major abdominal surgery: insights from microdialysis and population pharmacokinetic modelling.

  2019cites this paper